Shandong Daohe Pharmaceutical

Shandong Daohe Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale production of high-quality Active Pharmaceutical Ingredients (APIs) and advanced intermediates. Headquartered in Binzhou, Shandong, the company operates modern manufacturing facilities that adhere to international Good Manufacturing Practice (GMP) standards. Their product portfolio primarily focuses on small molecule therapeutics within the cardiovascular, metabolic, and anti-infective therapeutic areas. Key commercial products include widely used anticoagulants, antidiabetic agents, and heart failure treatments, serving both domestic and international markets. In addition to its own product line, Shandong Daohe provides comprehensive Contract Development and Manufacturing Organization (CDMO) services. These services encompass process development, pilot testing, and commercial-scale synthesis for global pharmaceutical partners. The company is recognized for its technical expertise in complex chemical synthesis and its commitment to quality and regulatory compliance.